FDA Answers Questions From ACE Webinar, Says ACE Requirements 'Outlined'
The Food and Drug Administration considers its Automated Commercial Environment filing requirements to be “outlined,” according to a list of questions and answers posted by Integration Point following a Dec. 10 webinar (see 1512110027). Responding to a question on whether…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
the agency’s required data elements are “locked down,” FDA said “any additional updates are refinements or clarifications, until such a time that new regulatory requirements indicate the need for further changes,” according to Integration Point, which hosted the webinar. The Q&A also includes information on the FDA ACE pilot, DUNS numbers, FDA’s “lockdown” policy of no changes to entry data within five days of arrival, and foreign-trade zones, among other topics.